Achyut Healthcare Ltd Stock Price Today (NSE: ACHYUT)

Achyut Healthcare Ltd

6.77+0.01 (+0.15%)
Market Closed

Fundamental Score

...

Achyut Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Achyut Healthcare Ltd share price today is 6.77, up +0.15% on NSE/BSE as of 22 September 2026. Achyut Healthcare Ltd (ACHYUT) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of 163.40 (Cr). The 52-week high for ACHYUT share price is 10.04 and the 52-week low is 4.70. At a P/E ratio of 501.68x, ACHYUT is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 0.96% and a debt-to-equity ratio of 0.04.

Achyut Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
7.40
Low
6.51
Volume
87.5K
Change
-1.83%

Achyut Healthcare Ltd share price chart: -1.83% return over the past month. 52-week high ₹10.04, 52-week low ₹4.70.

Achyut Healthcare Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
6.876.926.766.7640.24K (Cr)
6.626.856.626.8429.52K (Cr)
6.876.986.756.9023.84K (Cr)
6.976.976.506.9046.52K (Cr)
7.097.096.806.8221.14K (Cr)
6.717.076.666.9463.83K (Cr)
6.947.056.706.9936.54K (Cr)
6.956.956.816.9428.84K (Cr)
6.966.966.756.8125.25K (Cr)
6.997.206.956.9685.72K (Cr)

Achyut Healthcare Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
6.807.206.506.76-0.59%
6.487.426.486.89+6.33%
8.098.846.426.48-19.90%
5.7510.045.557.73+34.43%
5.486.054.705.77+5.29%
5.625.955.125.27-6.23%
5.305.994.875.27-0.57%
5.406.805.005.28-2.22%
5.545.975.005.07-8.48%
5.936.104.915.50-7.25%
5.535.984.985.84+5.61%
6.056.055.825.82-3.80%

Returns & Performance

Poor

Return on Equity (ROE)

0.96%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

1.22%

Returns generated on total capital deployed

Poor

Oper. Profit Margin (5Y Avg)

-1.13%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Achyut Healthcare Ltd Valuation Check

Poor

Price to Earnings (P/E)

501.68x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

34.89x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

47.40%

% shares held by company founders/management

Average

FII Holding

5.13%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-50.00%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

377.17%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

112.10%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-4.47%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

100.00%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.04x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

11.35x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-39.18 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Achyut Healthcare Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of ACHYUT across key market metrics for learning purposes.

Positive Indicators

7 factors identified

Strong Revenue Growth (377.17%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (112.10% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (100.00% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.04)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (11.35x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 9.32)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

9 factors identified

Below-Average Return on Equity (0.96%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (1.22%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Margin Pressure Concerns (-1.13%)

Observation: Operating margins are below industry standards.

Analysis: OPM <5% may indicate pricing pressures or cost management challenges.

Premium Valuation Risk (P/E: 501.68x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Profit Decline Concern (-50.00%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-4.47% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-39.18 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 5.13%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Achyut Healthcare Ltd vs Pharmaceuticals Peers

Peer Comparison - Pharmaceuticals

Compare Achyut Healthcare Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
39.8/100
7
₹163.40
501.7
Average
0.96%
Poor
1.22%
Poor
0.0
Excellent
100.00%
Excellent
112.10%
Excellent
0.00%
66.4/100
1841
₹441807.10
36.5
Average
14.74%
Average
19.31%
Good
0.0
Excellent
31.64%
Excellent
11.78%
Good
0.82%
56.3/100
9332
₹247298.00
84.7
Average
16.19%
Good
20.38%
Excellent
0.0
Excellent
5.29%
Good
8.67%
Good
0.41%
51.4/100
4964
₹168011.54
79.3
Average
27.07%
Excellent
14.09%
Average
1.8
Average
11.56%
Good
11.80%
Good
0.76%
74.1/100
1122
₹111935.68
25.0
Average
19.74%
Good
21.77%
Excellent
0.4
Excellent
18.76%
Excellent
12.45%
Good
0.09%
40.2/100
1362
₹110045.33
32.6
Average
11.82%
Average
15.67%
Good
0.0
Excellent
10.03%
Good
8.01%
Good
0.90%
34.1/100
1973
₹106575.12
97.4
Average
18.19%
Good
21.35%
Excellent
0.5
Excellent
-1.89%
Poor
7.19%
Good
0.13%
41/100
1173
₹97912.10
30.3
Average
11.75%
Average
14.80%
Average
0.2
Excellent
16.54%
Excellent
12.09%
Good
0.65%
24.6/100
1676
₹96414.02
26.2
Average
9.94%
Poor
14.54%
Average
0.2
Excellent
-8.07%
Poor
6.32%
Good
0.26%
83.4/100
2101
₹96045.36
17.4
Average
26.90%
Excellent
31.80%
Excellent
0.3
Excellent
34.39%
Excellent
13.02%
Good
0.72%
61.5/100
2273
₹93870.77
45.9
Average
12.49%
Average
13.56%
Average
0.4
Excellent
10.52%
Good
18.10%
Excellent
0.04%

Achyut Healthcare Ltd PE Ratio History

Historical price-to-earnings ratio for ACHYUT — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20240.02₹3.96198x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Achyut Healthcare Ltd Quarterly Performance

Latest quarterly metrics for ACHYUT — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

377.17%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-50.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

112.10%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

100.00%

Compounded annual net profit growth over 5 years

Achyut Healthcare Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for ACHYUT — calculated from daily price history

50RSI 14
Neutral — RSI 50

Momentum is balanced — neither overbought nor oversold.

SMA 50
7
▼ Price below SMA 50 — Short-term bearish
SMA 200
6
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
82K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Achyut Healthcare Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Achyut Healthcare Ltd (ACHYUT) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Achyut Healthcare Ltd

Loading latest quarterly results...

About ACHYUT (Achyut Healthcare Ltd)

Achyut Healthcare Ltd is a dynamic pharmaceutical company committed to delivering innovative healthcare solutions across India and beyond. From its state-of-the-art manufacturing f...acilities, Achyut formulates and distributes a diverse range of pharmaceutical products, meticulously crafted to meet the evolving needs of patients and healthcare professionals. The company’s portfolio encompasses a broad spectrum of therapeutic areas, featuring high-quality tablets, capsules, syrups, and injectable medications. A steadfast dedication to research and development allows Achyut to continuously expand its product offerings and improve existing treatments, ensuring patients have access to the most effective and advanced therapies available. Driven by a culture of excellence and integrity, Achyut strives to improve the health and well-being of communities it serves. At the heart of Achyut Healthcare’s operations is an unwavering commitment to quality and compliance. The company adheres to the strictest international standards in pharmaceutical manufacturing, ensuring that every product meets the highest benchmarks of safety, efficacy, and purity. Achyut's robust quality control systems encompass every stage of the production process, from sourcing raw materials to packaging and distribution. This dedication to quality extends beyond the manufacturing floor, encompassing a comprehensive approach to ethical business practices, environmental stewardship, and employee well-being. Achyut believes that by prioritizing quality in every aspect of its operations, it can build trust with patients, healthcare providers, and stakeholders alike. Headquartered in Ahmedabad, India, Achyut Healthcare leverages its strategic location and experienced workforce to efficiently serve a vast and growing market. With a strong domestic presence, Achyut also focuses on expanding its global footprint through strategic partnerships and export initiatives. The company’s commitment to innovation, quality, and accessibility has earned it a reputation as a reliable and trusted provider of pharmaceutical products. Achyut's vision is to be a leading force in the pharmaceutical industry, contributing to improved health outcomes and a better quality of life for people around the world. The company continues to invest in research, development, and infrastructure to achieve its mission and solidify its position as a leading healthcare provider.

Company Details

Symbol:ACHYUT
Industry:Pharmaceuticals
Sector:Pharmaceuticals

Key Leadership

Mr. Jigen Jagdishbhai Modi
MD, CFO & Executive Director
Mr. Kaushalkumar Shrikrishnabhai Dave
Company Secretary & Compliance Officer
Ms. Amisha Jigen Modi
Executive Director

ACHYUT Share Price: Frequently Asked Questions

What is the current share price of Achyut Healthcare Ltd?

Achyut Healthcare Ltd (ACHYUT) trades at ₹6.77 on NSE and BSE. Market cap ₹163.40 (Cr). Educational data only.

What is the P/E ratio of Achyut Healthcare Ltd?

Achyut Healthcare Ltd has a P/E of 501.68x vs industry average 34.89x.

What is the Bull Run score for Achyut Healthcare Ltd?

Achyut Healthcare Ltd has a Bull Run score of 39.8/100 based on 25+ financial parameters.

Does Achyut Healthcare Ltd pay dividends?

Achyut Healthcare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Achyut Healthcare Ltd?

Achyut Healthcare Ltd has ROE of 0.96%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Achyut Healthcare Ltd?

Achyut Healthcare Ltd has debt-to-equity of 0.04.

Is Achyut Healthcare Ltd a good investment?

Bull Run gives Achyut Healthcare Ltd a score of 39.8/100. This is not investment advice — consult a SEBI-registered advisor.